Bell Asset Management Ltd lowered its stake in shares of Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 21.3% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 9,608 shares of the semiconductor company’s stock after selling 2,606 shares during the period. Bell Asset Management Ltd’s holdings in Synopsys were worth $4,926,000 at the end of the most recent quarter.
Other institutional investors have also bought and sold shares of the company. Nuveen LLC purchased a new stake in Synopsys in the first quarter worth $341,480,000. Generation Investment Management LLP bought a new position in shares of Synopsys during the 1st quarter worth $240,491,000. Vanguard Group Inc. grew its stake in shares of Synopsys by 2.4% during the 1st quarter. Vanguard Group Inc. now owns 14,829,770 shares of the semiconductor company’s stock worth $6,359,747,000 after acquiring an additional 346,994 shares during the period. Aspex Management HK Ltd increased its holdings in Synopsys by 106.0% in the 2nd quarter. Aspex Management HK Ltd now owns 645,895 shares of the semiconductor company’s stock worth $331,137,000 after acquiring an additional 332,364 shares during the last quarter. Finally, Alliancebernstein L.P. increased its holdings in Synopsys by 22.2% in the 1st quarter. Alliancebernstein L.P. now owns 1,725,211 shares of the semiconductor company’s stock worth $739,857,000 after acquiring an additional 313,218 shares during the last quarter. Hedge funds and other institutional investors own 85.47% of the company’s stock.
Synopsys Price Performance
Shares of NASDAQ:SNPS opened at $409.68 on Thursday. The company has a 50 day moving average of $443.27 and a 200 day moving average of $508.76. The company has a current ratio of 1.62, a quick ratio of 1.51 and a debt-to-equity ratio of 0.52. The stock has a market cap of $76.10 billion, a P/E ratio of 32.16, a P/E/G ratio of 5.02 and a beta of 1.10. Synopsys, Inc. has a 12 month low of $365.74 and a 12 month high of $651.73.
Insiders Place Their Bets
In other Synopsys news, CEO Sassine Ghazi sold 11,366 shares of the company’s stock in a transaction dated Tuesday, September 2nd. The stock was sold at an average price of $589.01, for a total value of $6,694,687.66. Following the transaction, the chief executive officer directly owned 71,615 shares in the company, valued at $42,181,951.15. This represents a 13.70% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CFO Shelagh Glaser sold 3,655 shares of the firm’s stock in a transaction dated Friday, September 5th. The shares were sold at an average price of $609.77, for a total value of $2,228,709.35. Following the completion of the sale, the chief financial officer directly owned 15,317 shares in the company, valued at approximately $9,339,847.09. The trade was a 19.27% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold 30,894 shares of company stock valued at $16,760,783 in the last ninety days. Corporate insiders own 0.62% of the company’s stock.
Analyst Ratings Changes
SNPS has been the subject of a number of research reports. KeyCorp cut their target price on shares of Synopsys from $660.00 to $590.00 and set an “overweight” rating for the company in a research report on Wednesday, September 10th. Stifel Nicolaus lowered their price target on shares of Synopsys from $650.00 to $550.00 and set a “buy” rating on the stock in a research report on Wednesday, September 10th. Citigroup started coverage on shares of Synopsys in a report on Monday. They issued a “buy” rating and a $580.00 price objective for the company. Piper Sandler reduced their price objective on shares of Synopsys from $660.00 to $630.00 and set an “overweight” rating for the company in a research note on Wednesday, September 10th. Finally, Rosenblatt Securities reissued a “neutral” rating and set a $605.00 target price (down previously from $650.00) on shares of Synopsys in a report on Wednesday, September 10th. Ten research analysts have rated the stock with a Buy rating, six have issued a Hold rating and two have issued a Sell rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus price target of $556.33.
Check Out Our Latest Stock Analysis on Synopsys
Synopsys Profile
Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.
Featured Stories
- Five stocks we like better than Synopsys
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- Why Gold Loves Trump as Much as Trump Loves Gold
- How to Calculate Return on Investment (ROI)
- Google’s Gemini 3 Sends Broadcom Soaring: TPUs Take Center Stage
- What is a Special Dividend?
- Palantir Isn’t Just Riding the AI Boom—It’s Orchestrating It
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
